Back

Pro-inflammatory innate-like T cells are expanded in the blood and inflamed intestine in Crohn's Disease

Chiarolla, C. M.; Schulz, A. R.; Meir, M.; Reu-Hofer, S.; Romero Olmedo, A. J.; Lohoff, M.; Rosenwald, A.; Chang, H.-D.; Schlegel, N.; Mei, H.; Berberich-Siebelt, F.

2022-05-14 allergy and immunology
10.1101/2022.05.12.22274864 medRxiv
Show abstract

A complex and tissue-specific network of cells including T lymphocytes maintains intestinal homeostasis. To address disease and tissue-specific alterations, we performed a T cell-centric mass cytometry analysis of peripheral and intestinal lymphocytes from patients with Crohns disease (CD) and healthy donor PBMCs. We compared inflamed and not inflamed tissue areas of bowel resections. Chronic inflammation enforced activation, exhaustion and terminal differentiation of CD4+ and CD8+ T cells and an enrichment of CD4+Foxp3+ cells (Tregs) in inflamed intestine. However, tissue-repairing Tregs decreased, while enigmatic rare Foxp3+ T-cell subsets appeared upon inflammation. In vitro assays revealed that those subsets, e.g. CD4+Foxp3+HLA-DR+TIGIT- and CD4+Foxp3+CD56+, express pro-inflammatory IFN-{gamma}. Some T-conventional (Tcon) cells tended towards innateness. In blood of CD patients, not well studied CD4+ and CD8+ subsets of CD16+CCR6+CD127+ T cells appeared anew, a phenotype reproducible by incubation of healthy blood T cells with patient blood plasma. Together, these findings suggest a bias towards innate-like pro-inflammatory Tregs and innate-like Tcon, which act with less specific cytotoxicity. Most likely, this is both cause and consequence of intestinal inflammation during CD. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=177 HEIGHT=200 SRC="FIGDIR/small/22274864v1_ufig1.gif" ALT="Figure 1"> View larger version (81K): org.highwire.dtl.DTLVardef@a72ac0org.highwire.dtl.DTLVardef@e7a7b0org.highwire.dtl.DTLVardef@b21f8forg.highwire.dtl.DTLVardef@36077e_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Frontiers in Immunology
586 papers in training set
Top 0.3%
14.8%
2
Mucosal Immunology
42 papers in training set
Top 0.1%
12.4%
3
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.1%
10.5%
4
Clinical Immunology
21 papers in training set
Top 0.1%
4.3%
5
PLOS ONE
4510 papers in training set
Top 39%
3.6%
6
Life Science Alliance
263 papers in training set
Top 0.1%
3.6%
7
Allergy
23 papers in training set
Top 0.2%
3.1%
50% of probability mass above
8
Immunology
29 papers in training set
Top 0.3%
2.1%
9
European Journal of Immunology
57 papers in training set
Top 0.2%
1.9%
10
JCI Insight
241 papers in training set
Top 3%
1.9%
11
Cellular & Molecular Immunology
14 papers in training set
Top 0.8%
1.7%
12
Cell Reports Medicine
140 papers in training set
Top 4%
1.7%
13
Cells
232 papers in training set
Top 2%
1.7%
14
Cell Reports
1338 papers in training set
Top 26%
1.5%
15
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.4%
1.5%
16
iScience
1063 papers in training set
Top 19%
1.3%
17
eLife
5422 papers in training set
Top 47%
1.3%
18
Frontiers in Pharmacology
100 papers in training set
Top 3%
1.3%
19
The Lancet Rheumatology
11 papers in training set
Top 0.1%
1.3%
20
Journal of Clinical Medicine
91 papers in training set
Top 4%
1.2%
21
Journal of Translational Medicine
46 papers in training set
Top 1%
1.2%
22
Pharmaceuticals
33 papers in training set
Top 1%
0.9%
23
eBioMedicine
130 papers in training set
Top 4%
0.8%
24
Inflammatory Bowel Diseases
15 papers in training set
Top 0.3%
0.7%
25
Nature Communications
4913 papers in training set
Top 63%
0.7%
26
Stem Cell Research & Therapy
30 papers in training set
Top 0.9%
0.7%
27
Scientific Reports
3102 papers in training set
Top 76%
0.7%
28
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 46%
0.7%
29
Clinical & Translational Immunology
22 papers in training set
Top 0.3%
0.7%
30
Journal of Leukocyte Biology
40 papers in training set
Top 0.5%
0.7%